Loading…

Bioevaluation methods for iron-oxide-based magnetic nanoparticles

[Display omitted] •Iron-oxide-based magnetic nanoparticles (MNPs) lack use in the clinic.•In-vitro bioevaluation of MNPs in the literature is not universally applicable.•The main in-vitro bioevaluation is for cytotoxicity, cellular uptake, cell morphology.•In-vitro bioevaluation of MNPs should focus...

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics 2021-03, Vol.597, p.120348-120348, Article 120348
Main Authors: Dragar, Črt, Kralj, Slavko, Kocbek, Petra
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •Iron-oxide-based magnetic nanoparticles (MNPs) lack use in the clinic.•In-vitro bioevaluation of MNPs in the literature is not universally applicable.•The main in-vitro bioevaluation is for cytotoxicity, cellular uptake, cell morphology.•In-vitro bioevaluation of MNPs should focus on the intended in-vivo application. Despite the intensive development and unique properties of iron-oxide-based magnetic nanoparticles (MNPs), their use as drug delivery systems has not yet entered clinical practice. There also remains a lack of data on their toxicity profile and behavior in the bioenvironment. A number of in-vitro studies have been performed, but these were carried out with various MNPs using various methods of bioevaluation and various cell lines, so they are not universally applicable. It is of vital importance that selection of any experimental set-up and parameters for MNP bioevaluation, as well as the cell lines used, are focused on the final application of the MNPs. In this review, the most commonly used in-vitro methods for bioevaluation of MNPs are presented, including their key advantages and shortcomings. This critical comparison of these methods should facilitate selection of the appropriate in-vitro bioevaluation methods, and define the already established protocols that are available in the literature. Thus, we present here the first comprehensive review of in-vitro bioevaluation methods currently available for MNP evaluation. Furthermore, we provide important guidelines for selection of the best method, to enable reliable comparisons of the biological properties of different MNPs, and hence to promote their efficient translation from research to clinical practice.
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2021.120348